Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kamal Tabti

8PUBLICATIONS

28CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 27, 2024

Efficient Synthesis, Structural Characterization, Antibacterial Assessment, ADME-Tox Analysis, Molecular Docking and Molecular Dynamics Simulations of New Functionalized Isoxazoles.

Aziz Arzine, Hanine Hadni, Khalid Boujdi

|Dec 07, 2023

QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.

Abdelmoujoud Faris, Ibrahim M Ibrahim, Radwan Alnajjar

|Oct 20, 2023

<i>In silico</i> computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors.

Abdelmoujoud Faris, Ivana Cacciatore, Ibrahim M Ibrahim

|Jun 20, 2023

In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives.

Abdelmoujoud Faris, Hanine Hadni, Ibrahim M Ibrahim

|Jun 15, 2023

<i>In silico</i> screening of a series of 1,6-disubstituted 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines as potential selective inhibitors of the Janus kinase 3.

Abdelmoujoud Faris, Hanine Hadni, Basil A Saleh

|Dec 19, 2022

Discovery of anti-colon cancer agents targeting wild-type and mutant p53 using computer-aided drug design.

Hanine Hadni, Menana Elhallaoui

Pageof 2

Frequent Collaborators

4 joint publications

Abdelmoujoud Faris

3 joint publications

Ibrahim M Ibrahim

1 joint publications

Basil A Saleh

1 joint publications

Hadjer Khelfaoui

1 joint publications

Dalal Harkati

1 joint publications

Hassan Ait Ahsaine

1 joint publications

Menana Elhallaoui

1 joint publications

Gamal A El-Hiti

1 joint publications

Radwan Alnajjar

1 joint publications

Mashooq Ahmad Bhat

Frequent Collaborators

4 joint publications

Abdelmoujoud Faris

3 joint publications

Ibrahim M Ibrahim

1 joint publications

Basil A Saleh

1 joint publications

Hadjer Khelfaoui

Top Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on : Feb 09, 2021

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

See more related videos

Top Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on : Feb 09, 2021

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on : Dec 07, 2014

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on : Oct 26, 2015

See more related videos